Fred Hutch hematologists highlight findings on making stem cell transplants safer and more effective at the 2026 Tandem Meetings.
Read more: https://bit.ly/4sGtzHy
#stemcelltransplants #Tandem26
Be sure to stay through the end—
you won’t believe which past job most people find more conversation‑worthy than her prior role at Cosmopolitan in Manhattan.
🎧 LISTEN NOW: open.spotify.com/episode/5CUt...
🎙️ Recorded LIVE from our booth at #Tandem26
#BMT #TransplantRadio #MyelomaAwarenessMonth
“In general, there’s an increase in the use of transplants because of the availability of donors, but at the same time we still lag behind in terms of, ‘How do we get equal access to everyone?’” Fred Hutch's Dr. Albert Yeh on key themes from #Tandem26: https://bit.ly/4aSk7d1
“In general, there’s an increase in the use of transplants because of the availability of donors, but at the same time we still lag behind in terms of, ‘How do we get equal access to everyone?’” Fred Hutch's Dr. Albert Yeh on key themes from #Tandem26: https://bit.ly/4aSk7d1
- Orca-T shows faster recovery vs SOC.
- Median: 12 vs 13 days (neutrophils); 12 vs 17 days (platelets).
- Improved physical/mental health at day 180.
- Data from #Tandem26 via @astct.bsky.social @cibmtr.bsky.social.
Read the review: https://bit.ly/3OyOmOx
#Hematology #HCT #CellTherapy
REVEAL study: Axatilimab + ruxolitinib achieved 69% ORR in R/R #cGvHD. 🩺
60% of patients reported ≥1 Grade 3 TEAE.
20.5% experienced Grade 4.
Findings from #Tandem26 via @astct.bsky.social @cibmtr.bsky.social
Read the review: https://bit.ly/4cyLJ9o
#Hematology #GvHD #MedicalNews
Meredith shares her 25‑year journey living with chronic GvHD, the evolution of support resources, and how organizations like the #GVHDAlliance are pushing the field forward.
🎙️ Recorded LIVE from our booth at #Tandem26
#aGVHD #TransplantRadio
Many thanks to @onclive.bsky.social for reviewing our #Tandem26 abstract on outcomes of CD20 bispecifics after CD19 CAR in R/R MCL, an analysis from the CUBIC Consortium. #lymsm #tcellrx
Abstract link: www.astctjournal.org/article/S266...
www.onclive.com/view/real-wo...
Don't miss this! Abstracts from #Tandem26 are now available to view online. Explore the full collection here: www.astctjournal.org/issue/S2666-...
It’s your last chance to visit us at #Tandem26 in booth T225! Stop by to discover #SITC membership benefits, learn about upcoming events and find out about our upcoming Scientist Interest Groups (SIGs)!
Thank you to all who joined our collaborative #Tandem26 session, we appreciate the thoughtful discussions on cellular therapy! Continue the scientific exchange at our 2026 Spring Scientific, featuring the latest on next-generation cellular therapies: https://ow.ly/FEp250XSzsE
🔊 Listen to this exclusive interview with Dr. James L.M. Ferrara (Icahn School of Medicine at Mount Sinai) on Transplant Radio™ in booth 511 at #Tandem26!
🎧 Listen Now: lnkd.in/gESGm4R8
#agvhd #Tandem2026 #TransplantRADIO
What is an overused oncology buzzword❓Experts at #Tandem26 weighed in with their own hot takes. 🤔
@astct.bsky.social @cibmtr.bsky.social #lymsm #leusm #melsm #oncology #hematology #AI
Check out the video here ➡️: www.onclive.com/shorts/overu...
#tandem26 tradition - @astct.bsky.social Past President's Breakfast
Watch 👀: Amrita Desai, MD, MPH of @ohsunews.bsky.social discusses lifileucel in metastatic melanoma at #Tandem26.
#melsm #oncology @astct.bsky.social @cibmtr.bsky.social
See the whole video here ➡️: onclive.com/shorts/tackl...
Are you at #Tandem26 Meetings? Stop by booth T225 to learn more about SITC’s 41st Annual Meeting! #SITC26 is the perfect opportunity to share your research, learn about the latest in immuno-oncology and network with experts in the field.
It's the final day to come see us at #Tandem26!
📍 Visit NMDP at Booth #T430 to connect with our team
➕ Complete the Lifesaver Loop by visiting our partners and learning of our impactful collaboration for a chance to win a prize!
WATCH: Kenneth Jin Chang Lim, MBBS, discusses a study investigating the use of dexamethasone prophylaxis to reduce rates of neurotoxicity in myeloma with high ALC after CAR T-cell therapy. @astct.bsky.social @cibmtr.bsky.social #Tandem26 #hematology #mmsm
www.onclive.com/view/dr-lim-...
WATCH: Peter Riedell, MD, discusses the long-term efficacy of tisagenlecleucel in the third-line setting in patients with relapsed/refractory follicular lymphoma. @astct.bsky.social @cibmtr.bsky.social #Tandem26 #lymsm #hematology
www.onclive.com/view/dr-ried...
Thanks to Dr Alfonso Molina, of @stanfordhealthcare.bsky.social, for joining us at #Tandem26 to share findings with Orca-T and allogeneic CAR-T cell therapy in B-ALL! See our site for more from the meeting. @astct.bsky.social @cibmtr.bsky.social #leusm #hematology
www.onclive.com/conference/tct
Thank you to Dr Amrita Desai, of @ohsunews.bsky.social, for stopping by during #Tandem26 to chat about real-world outcomes with lifileucel in melanoma! See our site for more from the meeting. @astct.bsky.social @cibmtr.bsky.social #melsm
www.onclive.com/conference/tct
A huge thanks to Dr Fernando Duarte, who sat down with us at #Tandem26 to discuss the use of allogeneic HCT in MDS in Brazil! Check out our site for more of today's exclusive meeting coverage! @astct.bsky.social @cibmtr.bsky.social #hematology
www.onclive.com/conference/tct
What do you bring with you to every conference❓
Check out how experts at #Tandem26 answered. 😂
@astct.bsky.social @cibmtr.bsky.social #mmsm #lymsm #leusm #oncology
#hematology
Watch the whole video here ➡️: www.onclive.com/shorts/hemat...
#tandem26 Ferrara: JAKi facilitates tissue repair whereas steroids actually inhibit it (even though, yes, they do inhibit alloimmune responses). Ferrara’s goal is to move steroids to 2nd line tx for GVHD!
#tandem26 Ferrara: thus far, most GVHD pox/treatment has focused on the intimation and persistence of the alloimmune response, but efforts to improve tissue resistance to damage are important. Eg, intestinal stem cells are damaged by GVHD cytokines. Rux prevents ISC apoptosis, but steroids don’t.
#tandem26 Ferrara: refinement of biomarker + clinical sx based aGVHD stratification (MAGIC composite) now gives greater clarity in predicting outcomes at onset of aGVHD.
#tandem26 Ferrara: beautiful and touching start to his E Don Thomas lecture by dedicating the talk to John Galvin, who we shockingly lost this past year at far, far too young an age.
#tandem26 Unfortunately, I could only make the end of Stella Davies’s Bortin Lecture, but absolute respect to her for using her platform to speak out against the anti-immigrant, anti-democratic trajectory of our current course in America! “We can not sit this one out.” Agree 1000000% !!!
A special congratulations to Dr. Stella Davies, our #Tandem26 Mortimer M. Bortin lecturer! It is our pleasure to now hear, “Waiting until Evening to See How Splendid the Day Has Been: Aging and Transplant at the Extremes of the Lifespan” this evening!